1. Translational progress on tumor biomarkers
- Author
-
Evan T. Keller, Qian Liu, Qian-Qian Chen, Qinghua Zhou, Hongwei Guo, Liye Xie, Xiaolin Zhou, Jian-Jian Zhang, and Yi-Xin Lu
- Subjects
Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Invited Review ,business.industry ,medicine.medical_treatment ,Translational medicine ,Cancer ,General Medicine ,medicine.disease ,Bioinformatics ,Targeted therapy ,Tumor Biomarkers ,translational medicine ,Oncology ,Basic research ,tumor biomarkers ,medicine ,Cancer biology ,Intensive care medicine ,business - Abstract
There is an urgent need to apply basic research achievements to the clinic. In particular, mechanistic studies should be developed by bench researchers, depending upon clinical demands, in order to improve the survival and quality of life of cancer patients. To date, translational medicine has been addressed in cancer biology, particularly in the identification and characterization of novel tumor biomarkers. This review focuses on the recent achievements and clinical application prospects in tumor biomarkers based on translational medicine.
- Published
- 2015